Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC
david achaintre
PloS one, 2015
View PDFchevron_right
Correlation of Serum Acylcarnitines with Clinical Presentation and Severity of Coronary Artery Disease
stratos karag
Biomolecules, 2022
View PDFchevron_right
Pilot Experience with an External Quality Assurance Scheme for Acylcarnitines in Plasma/Serum
Leifur Franzson
JIMD Reports, 2016
View PDFchevron_right
Daily variation of serum acylcarnitines and amino acids
Virginia Kraus
Metabolomics, 2012
View PDFchevron_right
Circulating amino acids and acylcarnitines correlated with different CAC score ranges in diabetic postmenopausal women using LC–MS/MS based metabolomics approach
Pooneh Salari
BMC Endocrine Disorders
View PDFchevron_right
The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus
Xilin Yang
Frontiers in Endocrinology, 2020
View PDFchevron_right
Faculty of 1000 evaluation for Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples
Eli Riekeberg
F1000 - Post-publication peer review of the biomedical literature, 2017
View PDFchevron_right
Cardiovascular Risk Factors Associated with Blood Metabolite Concentrations and Their Alterations over a 4-Year Period in a Population-Based Cohort
Jerzy Adamski
Circulation: Cardiovascular Genetics, 2016
View PDFchevron_right
Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort
Rebecca Emeny
Circulation: Cardiovascular Genetics, 2016
View PDFchevron_right
Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects
Ronald Wanders
Journal of inherited metabolic disease, 1999
View PDFchevron_right
Differences between acylcarnitine profiles in plasma and bloodspots
Hubertus Prinsen
Molecular Genetics and Metabolism, 2013
View PDFchevron_right
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
zumrut duygu Sen
Pharmacological Reviews
View PDFchevron_right
Separation and identification of plasma short-chain acylcarnitine isomers by HPLC/MS/MS for the differential diagnosis of fatty acid oxidation defects and organic acidemias
Magdalena Ugarte
Journal of Chromatography B, 2007
View PDFchevron_right
Reproducibility of Metabolomic Profiles among Men and Women in 2 Large Cohort Studies
Amy Deik
Clinical Chemistry, 2013
View PDFchevron_right
Quantitative acylcarnitine determination by UHPLC-MS/MS - Going beyond tandem MS acylcarnitine "profiles
Charles Hoppel
Molecular genetics and metabolism, 2015
View PDFchevron_right
Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris
Gunnar Mellgren
Journal of the American Heart Association, 2017
View PDFchevron_right
Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples
Jerzy Adamski
PLoS ONE, 2014
View PDFchevron_right
Analysis of acylcarnitines in normal human urine with the radioisotopic exchange-high performance liquid chromatography (HPLC) method
Janos Kerner
Clinica Chimica Acta, 1989
View PDFchevron_right
Quantification of Carnitine and Acylcarnitines in Biological Matrices by HPLC Electrospray Ionization- Mass Spectrometry
Janos Kerner
Clinical Chemistry, 2008
View PDFchevron_right
Determination of urinary acylcarnitines: a complementary aid for the high-risk screening of several organic acidurias using a simple and reliable GC/MS-based method
Yves Giguere
Clinical Biochemistry, 2000
View PDFchevron_right
cis-3,4-Methylene-heptanoylcarnitine: Characterization and verification of the C8:1 acylcarnitine in human urine
Charles Hoppel
Journal of Chromatography B, 2007
View PDFchevron_right
Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
Jianhong Ching
BMJ Open Diabetes Research & Care, 2020
View PDFchevron_right
Plasma acylcarnitines and amino acids in dyslipidemia: an integrated metabolomics and machine learning approach
Fatemeh Bandarian
View PDFchevron_right
Reliability of fasting plasma alkylresorcinol metabolites concentrations measured 4 months apart
Afaf Kamal-Eldin
European Journal of Clinical Nutrition, 2012
View PDFchevron_right
Plasma acylcarnitines and risk of lower-extremity functional impairment in older adults: a nested case–control study
Antonio Buño
Scientific Reports, 2021
View PDFchevron_right
Reporting the accuracy of biochemical measurements for epidemiologic and nutrition studies
Bruce Turnbull
View PDFchevron_right
Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults
Andreas Schulze
Clinica Chimica Acta, 2003
View PDFchevron_right
Serum Levels of Acylcarnitines Are Altered in Prediabetic Conditions
Michael Stumvoll
PLoS ONE, 2013
View PDFchevron_right
Metabolomics in Epidemiology: Sources of Variability in Metabolite Measurements and Implications
Xiao-Ou Shu
Cancer Epidemiology, Biomarkers & Prevention, 2013
View PDFchevron_right
Plasma acylcarnitine levels increase with healthy aging
Michael Orr
Aging, 2020
View PDFchevron_right
Predicting Circulating Human Metabolites: How Good Are We?
shelby anderson
Chemical Research in Toxicology, 2009
View PDFchevron_right
A Plasma Long-Chain Acylcarnitine Predicts Cardiovascular Mortality in Incident Dialysis Patients
Sahir Kalim
Journal of the American Heart Association, 2013
View PDFchevron_right
Reliability of plasma polar metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry
Kazuyo Kuwabara
PloS one, 2018
View PDFchevron_right